inoculation
[대역어] 접종
[용어속성] Term
[용어속성] Term
ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants
ChAdOx1 nCoV-19(AZD1222) 또는 nCoV-19-Beta(AZD2816)는 베타 델타 및 오미크론 변종으로부터 시리아 햄스터를 보호합니다.
Article
[키워드] Antibody titer
AZD1222
Beta
ChAdOx1
ChAdOx1 nCoV-19
clinical trials
Delta
delta variant
Efficacy
evaluate the effect
full-length
hamster
hamsters
Heterologous
include
inoculation
lung
Lungs
Neutralizing antibody titer
omicron
post inoculation
PROTECT
Protective
Protein
real-world data
reduced
reduction in
regimen
S protein
S proteins
SARS-CoV-2
sequence
sgRNA
shown
simian adenovirus-vectored vaccine
single dose
Substitution
substitutions
symptomatic disease
the S protein
vaccination
Vaccine
variant
variants
variants of concern
vectored vaccine
Viral
virus
VOCs
Wuhan-1
[DOI] 10.1038/s41467-022-32248-6 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-022-32248-6 PMC 바로가기 [Article Type] Article
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay
살아있는 바이러스 SARS-CoV-2 중화 분석의 최적화 및 평가
Article
[키워드] 24 hour
24 hours
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
added
antibody
application
calculated
cell monolayer
cell suspension
cells
clinical isolates
Coefficient of variance
coronavirus
correlated
correlation
Critical
described
dose
ELISA
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
evaluated
functional antibody response
functional antibody responses
growth
immune evasion
Immunity
include
Incubation period
infecting
Influenza
Influenza virus
inoculation
isolates
Live virus
microneutralization
neutralization
Neutralization assay
neutralization titers
nucleocapsid protein
optimization
parameter
Post-infection
Precision
protein level
reduced
replicating virus
respiratory
SARS-CoV-2
SARS-CoV-2 clinical isolate
SARS-CoV-2 clinical isolates
SARS-CoV-2 microneutralization assay
SARS-CoV-2 neutralization
severe acute respiratory syndrome Coronavirus
the SARS-CoV-2
the strongest
therapeutic
Vaccine
variance
Vero E6
Vero E6 cell
VERO E6 cells
Viral
Viral variants
virus
virus infection
virus inhibition
virus inoculum
virus neutralization assays
Virus titration
was determined
WHO
[DOI] 10.1371/journal.pone.0272298 PMC 바로가기 [Article Type] Article
[DOI] 10.1371/journal.pone.0272298 PMC 바로가기 [Article Type] Article
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
hACE2 형질전환 마우스에서 SARS-CoV-2 감염 후 시간적 뇌 병변
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Affect
Analysis
animal model
astrogliosis
Beta
Brain
cause
Central nervous system
Cerebellum
characterized
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
develop
different time points
distribution
Encephalitis
hACE2
hACE2-transgenic mice
histopathological
immunohistochemistry
immunolabeling
inoculation
lesion
meningoencephalitis
mice
mucosa
necropsies
necropsy
Neuroinflammation
Neurological disease
neuronal
neurons
Neuropathology
nonsuppurative
olfactory
other organ
other organs
panel of antibodies
panel of antibody
performed
post inoculation
processed
question
reached
Respiratory disease
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 lineage
SARS-CoV-2 neuroinvasion
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
spongiosis
Spread
susceptible
thrombosis
transgenic mice
vacuolar
vacuolar degeneration
variants
Vasculitis
virological assay
virological assays
virus
[DOI] 10.1177/03009858211066841 PMC 바로가기 [Article Type] Article
[DOI] 10.1177/03009858211066841 PMC 바로가기 [Article Type] Article
Investigation of Antibody Levels During Three Doses of Sinopharm/BBIBP Vaccine Inoculation
Sinopharm/BBIBP 백신 접종 3회 동안 항체 수준 조사
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
Analysis
antibody
antibody kinetics
antibody levels
antibody persistence
booster
booster dose
booster injection
chemiluminescent immunoassay
CLIA
conventional virus neutralization test
coronavirus
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
correlation
Course
COVID-19
COVID-19 vaccination
CPE
Critical
cut-off
Cytopathic effect
detect
dose
healthcare worker
Healthcare workers
IgA level
IgA levels
IgG
IgG antibodies
IgG antibody
IgM
Immunity
implementation
inactivated
injection
inoculated
inoculation
investigation
Level
neutralization test
Neutralizing antibodies
neutralizing antibody
peaked
RBD
receiver operating characteristic
receptor
remained
respiratory
ROC
SARS-CoV-2
sensitivity
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
Sinopharm
specific antibodies
specificity
vaccination
Vaccine
variety
virus neutralization test
VNT
[DOI] 10.3389/fimmu.2022.913732 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.913732 PMC 바로가기 [Article Type] Article
Acute cardiac side effects after COVID-19 mRNA vaccination: a case series
COVID-19 mRNA 백신 접종 후 급성 심장 부작용: 사례 시리즈
Case Reports
[키워드] affecting
age
analyzed
approval
Asymptomatic
BNT162b2
cardiac adverse event
cardiac adverse events
Cardiac arrhythmia
Case series
case sery
CDC criteria
chest pain
clinical
Clinical data
clinical information
Containment
COVID-19
defined
determined by
Diagnosis
Dyspnea
eight
Electrocardiography
elevated
female
females
Germany
healthy individuals
Hospitalization
Host
Infection
Inflammation
Information System
inoculation
magnetic resonance imaging
male
males
Mild
Moderna
MRI
mRNA
mRNA vaccination
mRNA vaccine
mrna-1237
mRNA-1273
myocarditis
occur
onset of symptoms
organ damage
pandemic
pathophysiology
Patient
patients
Pericarditis
Registered
reported
required
retrieved
risk factor
Risk factors
SARS-CoV-2
second dose
severe cases
severity
Side effect
Support
Symptom
symptom onset
the disease
the vaccine
troponin
troponin levels
vaccination
Vaccine
variants
viral mutation
was performed
[DOI] 10.1186/s40001-022-00695-y PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1186/s40001-022-00695-y PMC 바로가기 [Article Type] Case Reports
Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay
S-RBD 중화항체 분석에 기초한 불활성화된 SARS-CoV-2 백신의 혈청학적 반응성
Clinical Trial
Published on
Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술,
Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술,
[키워드] active immunization
age
Analysis
antibody
antibody reactivity
BMI
clinical trial
collected
correlated
correlation
COVID-19
domain
Effect
ELISA
evaluate the effect
Factors
focus
had no
healthcare worker
immune
immune response
immunization
immunogenicity
inactivated
Inactivated SARS-CoV-2 vaccine
Inactivated vaccine
inoculation
Logistic
neutralizing antibody
no effects
participated
positive rate
positive rates
positive sample
reactivity
regularity
S-RBD
S-RBD domain antibody.
SARS-CoV-2
SARS-CoV-2 vaccine
second vaccination
serum
the SARS-CoV-2
the vaccine
Vaccine
venous blood
[DOI] 10.1016/j.ijid.2022.01.064 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1016/j.ijid.2022.01.064 PMC 바로가기 [Article Type] Clinical Trial
Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)
비강 나노바디(Nb22)에 의해 부여된 hACE2 마우스의 SARS-CoV-2에 대한 단기 순간 예방 및 효율적인 치료
Article
[키워드] addition
Administered
Against
alpaca
binding
blocked
Breakthrough infection
breakthrough infections
caused
circulating
Community
Complete
COVID-19 vaccine
current
Delta
delta variant
demonstrated
doses
effective
Efficacy
efficient
exhibited
exhibiting
hACE2
highlight
immunized
Inhaled
inoculation
instantaneous
instantaneous prophylaxis
instantaneous protection
intranasal
long-lasting
nanobodies
nanobody
Nb22
neutralization
PrEP
Prophylaxis
RBD
reported
respiratory
Respiratory system
SARS-CoV-2
Seven
single dose
Spike protein
stability
STIP
Structural analysis
Structure
the spike protein
therapeutic
unmet need
variants
[DOI] 10.3389/fimmu.2022.865401 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.865401 PMC 바로가기 [Article Type] Article
Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study
SARS-COV-2에 의한 안구 표면 감염의 탐색 및 각막 기증에 대한 시사점 : 생체 외 연구
Research Article
[키워드] 24 hour
24 hours
ACE-2
acute respiratory syndrome
aims
Algorithms
angiotensin
angiotensin-converting enzyme 2
bulbar conjunctiva
cathepsin
cellular entry
Conjunctiva
Contamination
contraindication
contraindications
Cornea
Corneal
Corneal Graft
Corneal transplantation
coronavirus
coronavirus 2
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 crisis
Ct value
Culture
culture media
decrease
diagnosed
diagnosed with COVID-19
Donor
Donor selection
donors
enzyme
epithelial cell
epithelial cells
epithelium
evaluate
Evidence
Ex vivo
exacerbated
exploration
expresse
expressed
expression
expression of SARS-CoV-2
expression pattern
female
genetic material
healthy donor
immunohistochemistry
implication
IMPROVE
increase in
Infection
infectious dose
inoculation
involved
lack
limbus
limited sample size
mandatory
media
median
moderate
molecular
mRNA level
nasopharyngeal
Nasopharyngeal swab
nasopharyngeal swabs
Not contaminated
Ocular surface
organ
organ culture
pandemic
pathway
Patient
PCR
positive
Positive test
Postinfection
promote
promoted
Protein
qPCR
quantified
quantitative PCR
question
RdRP
receptor
Replication
researcher
respiratory
respond
retrieved
reverse transcription
Reverse transcription quantitative PCR
risk
risk of transmission
RNA
RNA copy
RNA sequence
RT-qPCR
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 receptor
SARS-CoV-2 receptors
SARS-CoV-2 RNA
SARS-CoV-2 viral
SARS-CoV-2 virus
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
significant increase
Support
TCID
tested
tissue
tissue culture
tissues
TMPRSS2
Transmission
utility
Viral
Viral detection
Viral RNA
was tested
were infected
worsened
[DOI] 10.1371/journal.pmed.1003922 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.1003922 PMC 바로가기 [Article Type] Research Article
Evaluation of virucidal activity of residual quaternary ammonium-treated surfaces on SARS-CoV-2
SARS-CoV-2에 대한 잔류 4차 암모늄 처리 표면의 살바이러스 활성 평가
Article
[키워드] Ammonium
Antimicrobials
Antiviral effect
applied
Belgium
biosafety level
BSL-3
communicability
conditions
conducted
contaminated surfaces
COVID-19
COVID-19 pandemic
Degradation
demonstrated
effective
evaluated
fomites
global health
HCoV
hCoV-19/Australia/VIC01/2020
Health
help
independent
indicate
inoculation
isolate
Laboratory
Level
methodology
performed
proliferation
qRT-PCR
Quantitative
reduce
reduction
reductions
Registered
residual
RNA
SARS-CoV-2
SARS-CoV-2 isolate
SARS-CoV-2 variant
silane
Support
supported
surfaces
sustained
Transmission
transmission of SARS-CoV-2
treated
Viral RNA
virion
virucidal
virulent
[DOI] 10.1016/j.ajic.2021.10.021 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ajic.2021.10.021 PMC 바로가기 [Article Type] Article